Skip to content
Screener

Integer Holdings ITGR Reportable Segment — SG&A

Similar metrics at other companies

Silicon Laboratories logo
SLABReportable Segment — SG&A
$55.49M+33.3%
Indivior Pharmaceuticals, Inc. logo
INDVReportable Segment — SG&A
$124M-6.8%
VGN
VGNTReportable Segment — SG&A
$97M-7.6%
BridgeBio Pharma logo
BBIOReportable Segment — SG&A
$163.9M+54.1%
QXO, Inc. logo
QXOReportable Segment — SG&A
$457.8M+1,792%
Agios Pharmaceuticals logo
AGIOReportable Segment — SG&A
$51.55M+12.4%

Other financials

Income statement

See full
Revenue$439.6M+0.5%
Gross profit$109.6M-8.9%
Operating income$31.9M-35.7%
Net income$16.5M+173%
EPS (diluted)$0.48+173%

Balance sheet

See full
Cash & equivalents$8.1M-74.4%
Total debt$1.4B+2.0%
Total equity$1.7B+5.6%
Total assets$3.4B+3.5%

Cash flow

See full
Operating cash flow$24.7M-21.0%
CapEx$24.0M-5.0%
Free cash flow$737.0K-87.8%

Valuation

See full
Market cap$4.29B+16.1%
Enterprise value$5.66B+13.4%
P/E30.2×-14.4×
P/S2.3×+0.3×

Profitability

See full
Gross margin26.4%-0.6pp
Operating margin11%-1.6pp
Net margin7.6%+3.2pp
FCF margin5.4%-1.0pp

Returns & leverage

See full
Return on equity8.6%+3.7pp
Debt / equity0.8×0.0×
Current ratio3.8×+0.4×

Where this comes from

Reported directly by Integer Holdings in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The source filing: Integer Holdings’s 10-K, filed February 23, 2026.

Filed
Feb 23, 2026, 8:03 AM EST
Fiscal year
FY2025
Accession
0001114483-26-000003
Line item202520242023
Cost of sales1,353,2511,257,5821,145,767
Gross profit500,386459,014409,889
Operating expenses:
Selling, general and administrative211,748185,202173,171
Research, development and engineering49,49953,42561,967
Restructuring and other charges17,87512,14911,428
Total operating expenses279,122250,776246,566
Operating income221,264208,238163,323

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Integer Holdings's reportable segment — SG&A?
Integer Holdings (ITGR) reported reportable segment — SG&A of $52.94M in Q4 2025.
How has Integer Holdings's reportable segment — SG&A changed year-over-year?
Integer Holdings's reportable segment — SG&A increased by 14.3% year-over-year, from $46.3M to $52.94M.
What is the long-term trend for Integer Holdings's reportable segment — SG&A?
Over 2 years (2023 to 2025), Integer Holdings's reportable segment — SG&A has grown at a 10.6% compound annual growth rate (CAGR), from $173.17M to $211.75M.
What does reportable segment — SG&A mean?
Captures the indirect operating costs required to support the segment, including sales, marketing, and general corporate overhead. This metric is used to evaluate the efficiency of the segment's administrative structure and its ability to scale operations.

Ask your AI about Integer Holdings's reportable segment — sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude